Key facts
- This page summarizes George A. Scangos's Form 4 filing for Vir Biotechnology, Inc. (VIR).
- 1 reported transaction and 0 derivative rows are listed below.
- Accepted by SEC: 25 Feb 2025, 15:44.
George A. Scangos - 24 Feb 2025 Form 4 Insider Report for Vir Biotechnology, Inc. (VIR)
- Reporting relationship
- Director
- Issuer ticker
- VIR
- Reported as of
- 24 Feb 2025
- Net transaction value
- -$95,063
- SEC form
- 4
- Accepted by SEC
- 25 Feb 2025, 15:44:56 UTC
- Prior SEC filing
- 19 Feb 2025
- Next SEC filing
- 18 Mar 2025
- Source filing
- View source filing
- Reporting owner signature
- /s/ Vanina de Verneuil, Attorney-In-Fact
Source evidence
Original filing metadata and source links for verification.
5 source fields
Reporting owner
1 detail
Key filing fact
George A. Scangos filed Form 4 for Vir Biotechnology, Inc. (VIR) on 25 Feb 2025.
Change
- Previous filing in this sequence was filed on 19 Feb 2025.
- Current net transaction value: -$95,063.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
View source filing
Ownership activity is grounded in SEC Form 4 disclosures.
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
VIR
transaction
Common Stock
Sale
- Transaction value
- $95,063
- Shares
- -10,056
- Change %
- -1.4%
- Price
- $9.45
- Shares after
- 698,239
- Date
- 24 Feb 2025
- Ownership
- Direct
- Footnotes
- F1
VIR
holding
Common Stock
No transaction description listed
- Transaction value
- Shares
- Change %
- Price
- Shares after
- 1,151,730
- Date
- 24 Feb 2025
- Ownership
- See footnote
- Footnotes
- F2
VIR
holding
Common Stock
No transaction description listed
- Transaction value
- Shares
- Change %
- Price
- Shares after
- 598,270
- Date
- 24 Feb 2025
- Ownership
- See footnote
- Footnotes
- F3
VIR
holding
Common Stock
No transaction description listed
- Transaction value
- Shares
- Change %
- Price
- Shares after
- 1,151,730
- Date
- 24 Feb 2025
- Ownership
- See footnote
- Footnotes
- F4
VIR
holding
Common Stock
No transaction description listed
- Transaction value
- Shares
- Change %
- Price
- Shares after
- 33,629
- Date
- 24 Feb 2025
- Ownership
- See footnote
- Footnotes
- F5
VIR
holding
Common Stock
No transaction description listed
- Transaction value
- Shares
- Change %
- Price
- Shares after
- 179,930
- Date
- 24 Feb 2025
- Ownership
- See footnote
- Footnotes
- F6
* marks a reported price that did not pass the local price check.
Additional SEC filing notes
Filing notes and footnotes
Rule 10b5-1 trading plan
These transactions were reported as open-market trades under a Rule 10b5-1 plan. The plan lets an insider set trading instructions in advance, which can reduce the risk of trading while in possession of material nonpublic information.
Original filing language: transaction made pursuant to a contract, instruction, or written plan intended to satisfy Rule 10b5-1(c).
Explanation of responses 6 footnotes
Footnote F1
Represents the automatic sale of shares to cover the Issuer's tax withholding and remittance obligation in connection with the vesting of restricted stock units.
Footnote F2
The shares are held in the name of the George A Scangos 2023 Annuity Trust, of which the reporting person and his spouse are Trustees.
Footnote F3
The shares are held by the spouse of the Reporting Person.
Footnote F4
The shares are held in the name of Leslie Wilson 2023 Annuity Trust, of which the reporting person and his spouse are Trustees.
Footnote F5
The shares are held in the name of George A. Scangos, as Trustee of the Scangos-Wilson Family Trust dated May 12, 2011.
Footnote F6
The shares are held in the name of the Scangos 2018 Grandchildren's Trust, of which the reporting person and his spouse are Trustees.